Speaker illustration

Doctor Lukasz Szyda

Bieganski Hospital, Lodz (Poland)

First-line treatment with oral anticoagulant predicts survival in acute cardiac patients with heparin-induced thrombocytopenia

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: e-Posters session


Dabigatran as first-line treatment for heparin-induced thrombocytopenia in the intensive cardiac care setting.

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Pharmacology and pharmacotherapy e-posters


ESC 365 is supported by

logo Novo Nordisk